Oncotype DX™ Breast Cancer Assay

Web link https://www.oncotypedx.com

	Next higher product group	pharmacogenomic/pharmacogenetic cancer test
	Status	2004-01-01 sales start
	Organisation	Genomic Health Inc. (Nasdaq: GHDX)
	Group	Exact Sciences (Group)

Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Oncotype DX™ Breast Cancer Assay

[1] Exact Sciences Corporation. (7/29/19). "Press Release: Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company". Madison, WI & Redwood City, CA....
[2] Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen....
[3] BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz....
[4] Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]